Goldman Sachs’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$860M Buy
1,931,760
+197,166
+11% +$87.8M 0.12% 131
2025
Q1
$841M Buy
1,734,594
+332,860
+24% +$161M 0.14% 114
2024
Q4
$564M Buy
1,401,734
+43,200
+3% +$17.4M 0.09% 168
2024
Q3
$632M Sell
1,358,534
-703,965
-34% -$327M 0.1% 159
2024
Q2
$967M Buy
2,062,499
+661,539
+47% +$310M 0.16% 93
2024
Q1
$586M Sell
1,400,960
-83,974
-6% -$35.1M 0.1% 165
2023
Q4
$604M Sell
1,484,934
-210,391
-12% -$85.6M 0.11% 146
2023
Q3
$590M Sell
1,695,325
-120,547
-7% -$41.9M 0.13% 124
2023
Q2
$639M Buy
1,815,872
+104,141
+6% +$36.6M 0.14% 116
2023
Q1
$539M Buy
1,711,731
+39,358
+2% +$12.4M 0.12% 132
2022
Q4
$483M Sell
1,672,373
-48,374
-3% -$14M 0.12% 147
2022
Q3
$498M Buy
1,720,747
+673,107
+64% +$195M 0.13% 113
2022
Q2
$295M Sell
1,047,640
-196,067
-16% -$55.2M 0.07% 228
2022
Q1
$325M Buy
1,243,707
+56,330
+5% +$14.7M 0.07% 241
2021
Q4
$261M Sell
1,187,377
-206,385
-15% -$45.3M 0.05% 317
2021
Q3
$253M Buy
1,393,762
+15,745
+1% +$2.86M 0.05% 301
2021
Q2
$278M Sell
1,378,017
-284,549
-17% -$57.4M 0.06% 260
2021
Q1
$357M Buy
1,662,566
+101,920
+7% +$21.9M 0.09% 172
2020
Q4
$369M Sell
1,560,646
-483,081
-24% -$114M 0.09% 163
2020
Q3
$556M Buy
2,043,727
+543,029
+36% +$148M 0.16% 86
2020
Q2
$436M Sell
1,500,698
-252,282
-14% -$73.2M 0.13% 123
2020
Q1
$417M Sell
1,752,980
-115,419
-6% -$27.5M 0.15% 111
2019
Q4
$409M Buy
1,868,399
+259,060
+16% +$56.7M 0.1% 170
2019
Q3
$273M Sell
1,609,339
-350,181
-18% -$59.3M 0.08% 244
2019
Q2
$359M Sell
1,959,520
-342,113
-15% -$62.7M 0.1% 169
2019
Q1
$423M Sell
2,301,633
-244,307
-10% -$44.9M 0.13% 122
2018
Q4
$422M Sell
2,545,940
-59,559
-2% -$9.87M 0.13% 110
2018
Q3
$502M Sell
2,605,499
-746,306
-22% -$144M 0.13% 125
2018
Q2
$570M Sell
3,351,805
-89,262
-3% -$15.2M 0.15% 103
2018
Q1
$561M Buy
3,441,067
+210,866
+7% +$34.4M 0.14% 123
2017
Q4
$484M Buy
3,230,201
+533,497
+20% +$79.9M 0.12% 147
2017
Q3
$410M Sell
2,696,704
-82,840
-3% -$12.6M 0.1% 156
2017
Q2
$358M Sell
2,779,544
-876,362
-24% -$113M 0.09% 167
2017
Q1
$400M Sell
3,655,906
-226,338
-6% -$24.8M 0.11% 131
2016
Q4
$286M Buy
3,882,244
+287,541
+8% +$21.2M 0.08% 188
2016
Q3
$313M Sell
3,594,703
-42,704
-1% -$3.72M 0.09% 159
2016
Q2
$313M Sell
3,637,407
-772,565
-18% -$66.5M 0.1% 151
2016
Q1
$351M Buy
4,409,972
+1,540,048
+54% +$122M 0.12% 133
2015
Q4
$361M Buy
2,869,924
+530,388
+23% +$66.7M 0.11% 135
2015
Q3
$244M Buy
2,339,536
+717,467
+44% +$74.7M 0.08% 191
2015
Q2
$200M Sell
1,622,069
-149,768
-8% -$18.5M 0.06% 281
2015
Q1
$209M Sell
1,771,837
-98,221
-5% -$11.6M 0.07% 273
2014
Q4
$222M Sell
1,870,058
-164,325
-8% -$19.5M 0.07% 248
2014
Q3
$228M Sell
2,034,383
-785,372
-28% -$88.2M 0.07% 216
2014
Q2
$267M Sell
2,819,755
-869,911
-24% -$82.4M 0.08% 209
2014
Q1
$261M Sell
3,689,666
-762,239
-17% -$53.9M 0.09% 200
2013
Q4
$331M Sell
4,451,905
-1,905,026
-30% -$142M 0.11% 147
2013
Q3
$482M Sell
6,356,931
-388,244
-6% -$29.4M 0.18% 75
2013
Q2
$540M Buy
+6,745,175
New +$540M 0.21% 58